Chemoinformaics analysis of 1,2(Beta-Pyridyl)Piperidine-Anabasine
| Molecular Weight | 162.236 | nRot | 1 |
| Heavy Atom Molecular Weight | 148.124 | nRig | 12 |
| Exact Molecular Weight | 162.116 | nRing | 2 |
| Solubility: LogS | 0.344 | nHRing | 2 |
| Solubility: LogP | 0.941 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 28.2351 |
| nHD | 1 | BPOL | 15.7549 |
| QED | 0.682 |
| Synth | 2.659 |
| Natural Product Likeliness | -0.086 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.007 |
| HIA | 0.01 |
| CACO-2 | -4.464 |
| MDCK | 0.00000963 |
| BBB | 0.804 |
| PPB | 0.149665 |
| VDSS | 2.568 |
| FU | 0.814198 |
| CYP1A2-inh | 0.101 |
| CYP1A2-sub | 0.781 |
| CYP2c19-inh | 0.188 |
| CYP2c19-sub | 0.862 |
| CYP2c9-inh | 0.014 |
| CYP2c9-sub | 0.453 |
| CYP2d6-inh | 0.138 |
| CYP2d6-sub | 0.89 |
| CYP3a4-inh | 0.362 |
| CYP3a4-sub | 0.459 |
| CL | 8.358 |
| T12 | 0.412 |
| hERG | 0.054 |
| Ames | 0.014 |
| ROA | 0.909 |
| SkinSen | 0.912 |
| Carcinogencity | 0.081 |
| EI | 0.046 |
| Respiratory | 0.949 |
| NR-Aromatase | 0.518 |
| Antiviral | No |
| Prediction | 0.867391 |